VYND · Vynleads, Inc.
$0.41
At close · Jun 25
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$7.51M
Shares
18.33M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$255.07K
+2.3%
FY2025
Gross Margin
-59485.71%
-52877.6pp
FY2022
Operating Margin
-533159.18%
-478040.8pp
FY2022
Diluted EPS
-$0.01
+50%
FY2025
Operating Cash Flow
-$108.86K
+3.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $49 | $484 | $48.26K | $396.69K | $1.82M | |
| $7475 | $5045 | $24.06K | -$25.94K | -$13.57K | -$11.06K | -$8188 | -$3416 | -$1727 | |
| $3069 | $6499 | $14.89K | $35.57K | $29.2K | $32.47K | $56.71K | $179.07K | $718.65K | |
| -$3069 | -$6499 | -$14.89K | -$35.57K | -$29.15K | -$31.98K | — | — | — | |
| — | — | — | — | -59485.71% | -6608.06% | — | — | — | |
| $264.52K | $240.82K | $224.35K | $200.16K | $232.1K | $234.79K | $362.95K | $278.22K | $756.81K | |
| $264.52K | $240.82K | $224.35K | $200.16K | $232.1K | $234.79K | $420.55K | $695.28K | $2.34M | |
| -$267.59K | -$247.32K | -$239.24K | -$235.73K | -$261.25K | -$266.77K | -$372.29K | -$298.59K | -$519.02K | |
| — | — | — | — | -533159.18% | -55118.39% | -771.39% | -75.27% | -28.47% | |
| — | $5045 | $24.06K | — | — | — | — | — | — | |
| — | — | $4717 | $0 | — | $6250 | $2000 | — | — | |
| -$275.16K | -$252.36K | -$258.58K | -$261.67K | -$271.12K | -$271.58K | -$378.48K | -$302.01K | -$520.75K | |
| — | -$2703 | -$2573 | -$1770 | -$2505 | $0 | $1154 | $1059 | -$907 | |
| -$277.86K | -$255.07K | -$261.19K | -$263.44K | -$273.62K | -$271.58K | -$379.63K | -$303.07K | -$519.84K | |
| — | — | — | — | -558414.29% | -56111.78% | -786.6% | -76.4% | -28.51% | |
| $277.86K | $255.07K | $261.19K | — | — | — | — | — | — | |
| USD/shares | -$0.02 | -$0.01 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | — | — | — |
| USD/shares | -$0.02 | -$0.01 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | — | — | — |
| shares | — | 18.33M | 12.79M | 11.6M | 11.6M | 11.6M | 11.47M | 11.4M | 11.72M |
| shares | — | 18.33M | 12.79M | 11.6M | 11.6M | 11.6M | 11.47M | 11.4M | 11.72M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Health Information Services median 1.82×
EV/EBIT
—
Health Information Services median 27.11×
P/E (TTM)
—
Health Information Services median 37.07×